June 27th, 2022
The startup will develop and commercialize cost-effective, highly sensitive and specific point-of-care diagnostics, applying a novel electrochemical sensor platform created at the Wyss Institute
May 20th, 2022
Through the Laboratory for Bioengineering Research and Innovation, Northpond will sponsor SomaCode to support commercialization
April 28th, 2022
Startup advances a unique CMOS-powered drug discovery platform that opens a new dimension in cell-based screening
March 15th, 2022
Harvard researchers spin ‘muscle’ fibers from vegetable plant proteins, launching alternative meat start-up
March 7th, 2022
Low-cost, multiplexed, electrochemical biomarker detection platform will be commercialized in point-of-care diagnostics
